Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Finance Watch: Hatteras Nearly Halfway To $200m Goal For New Early-Stage VC Fund
Apr 19 2019
•
By
Mandy Jackson
and
Ian Haydock
Hatteras' longtime focus on seed and early-stage investments is unchanged with new fund.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Financing
More from Business